The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
Panelists discuss how decisions to switch between Bruton tyrosine kinase (BTK) inhibitors are driven by multiple factors including intolerable toxicities, development of resistance mutations, disease ...
Meanwhile, AI translation tools have reached an impressive level of precision and can process text in a fraction of the time ...
Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...
Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...